Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England

BACKGROUND: The coronavirus pandemic resulted in many changes which had the potential to impact mortality related to opioid agonist therapy (OAT; methadone, buprenorphine), including changes in the prescribing and dispensing of OAT and patterns of drug availability and use. We aimed to assess the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldabergenov, D, Reynolds, L, Scott, J, Kelleher, MJ, Strang, J, Copeland, CS, Kalk, NJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531664/
https://www.ncbi.nlm.nih.gov/pubmed/36265326
http://dx.doi.org/10.1016/j.drugpo.2022.103877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531664/
https://www.ncbi.nlm.nih.gov/pubmed/36265326
http://dx.doi.org/10.1016/j.drugpo.2022.103877

Ejemplares similares